Health & WellnessTech

Gerostate Alpha (YC S18)

A pharmaceutical company dedicated to treating aging and age-related disease
San Francisco, 
CA
Investment type:
Equity
(SAFE)
Target raise:
$50,000
 - $1,070,000
Minimum investment:​
$100
End date:
Aug 10, 2021
ended
Share
Share on facebook
Share on twitter
Share on linkedin
Share on email
Highlights

  • ?? $2.1M raised in initial seed round, at $15M valuation cap
  • ?? Team at the forefront of aging research for decades, collectively authoring 200+ papers
  • ?? Our platform delivers drug candidates to slow aging at a success rate of 20%
  • ?? Funds will be used to test 10-15 of our hits in aging mice
Our Story

Gerostate Alpha is a new pharmaceutical company dedicated to treating aging and age-related disease. Incubating at the Buck Institute for Research on Aging, we develop breakthrough pharmaceuticals through proprietary innovations to mitigate and reduce the effects of aging.
Our Ambition

Phase 2/3 with multiple hits covering different aspects of aging, we will be the leading company revolutionizing medicine